LONDON, June 5, 2019
/PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the
global medical technology business, has announced the launch of its
CONQUEST FN™ system, a new implant solution to treat femoral neck
fractures and promote bone preservation.
Irrespective of age and bone quality, femoral neck fractures
pose a significant clinical challenge with complication rates
reported to be as high as 69% 1 depending on fracture
type, patient population and therapeutic intervention. Smith &
Nephew designed the CONQUEST FN system to address these
challenges by providing a combination of innovative instrument and
implant offerings with the intent of providing intra-operative and
post-operative reduction control.
Inadequate implant fixation can lead to post-operative
complications and secondary procedures. To address this concern,
Smith & Nephew collaborated with FX Devices and became the
first to utilize their POGO® Technology for femoral neck
fractures. The POGO telescoping compression screw is designed to
provide continuous fracture compression post-operatively with the
intent to decrease hip pain and post-operative complications.
Coupled with a proximal femoral locking plate, the system provides
surgeons with a new level of control when treating these
devastating fractures – dynamic locking fixation.
"Femoral neck fractures in physiologically young patients are
significant injuries. I have had positive results in my initial
experience with CONQUEST FN. Intra-operatively, it is easy to
implant without a threat of loss of reduction; and
post-operatively, patients often follow-up very comfortable with
minimal pain, and have progressed to weight-bearing more quickly. I
feel this speaks to the enhanced stability of the implant," said
Daniel S. Chan, MD, an orthopaedic
traumatologist with the Orthopaedic Trauma Institute in
Macon, Ga.
The estimated number of hip fractures worldwide will rise from
1.7 million in 1990 to 6.3 million in 2050. 2 Femoral
neck fractures represent approximately 50% of these
cases.3
"We take pride in designing products that address procedural
challenges when treating traumatic injuries and are excited to
introduce our CONQUEST FN system to a market that is clearly ready
for new solutions. It offers truly differentiating POGO Technology
that will help take femoral neck fracture treatment to the next
level by offering dynamic locking fixation and promoting bone
preservation – key elements in returning patients to pre-fracture
function. It further complements our comprehensive hip fracture
portfolio to give surgeons and their patients a choice of treatment
options," said Skip Kiil, President
of Global Orthopaedics, Smith & Nephew.
About Smith & Nephew
Smith & Nephew is a portfolio medical technology business
that exists to restore people's bodies, and their
self-belief. Smith & Nephew has leadership positions in
Orthopaedics, Advanced Wound Management and Sports Medicine, more
than 16,000 employees and a presence in more than 100 countries.
Annual sales in 2018 were $4.9
billion. Smith & Nephew is a member of the FTSE100
(LSE:SN, NYSE:SNN). For more information about Smith & Nephew,
please visit our corporate
website www.smith-nephew.com and follow us
on Twitter, LinkedIn or Facebook.
Forward-looking Statements
This document may contain forward-looking statements
that may or may not prove accurate. For example, statements
regarding expected revenue growth and trading margins, market
trends and our product pipeline are forward-looking statements.
Phrases such as "aim", "plan", "intend", "anticipate",
"well-placed", "believe", "estimate", "expect", "target",
"consider" and similar expressions are generally intended to
identify forward-looking statements. Forward-looking statements
involve known and unknown risks, uncertainties and other important
factors that could cause actual results to differ materially from
what is expressed or implied by the statements. For Smith &
Nephew, these factors include: economic and financial conditions in
the markets we serve, especially those affecting health care
providers, payers and customers; price levels for established and
innovative medical devices; developments in medical technology;
regulatory approvals, reimbursement decisions or other government
actions; product defects or recalls or other problems with quality
management systems or failure to comply with related regulations;
litigation relating to patent or other claims; legal compliance
risks and related investigative, remedial or enforcement actions;
disruption to our supply chain or operations or those of our
suppliers; competition for qualified personnel; strategic actions,
including acquisitions and dispositions, our success in performing
due diligence, valuing and integrating acquired businesses;
disruption that may result from transactions or other changes we
make in our business plans or organisation to adapt to market
developments; and numerous other matters that affect us or our
markets, including those of a political, economic, business,
competitive or reputational nature. Please refer to the documents
that Smith & Nephew has filed with the U.S. Securities and
Exchange Commission under the U.S. Securities Exchange Act of 1934,
as amended, including Smith & Nephew's
most recent annual report on Form 20-F, for a discussion of certain
of these factors. Any forward-looking statement is based on
information available to Smith & Nephew as of the date of the
statement. All written or oral forward-looking statements
attributable to Smith & Nephew are qualified by this caution.
Smith & Nephew does not undertake any obligation to update or
revise any forward-looking statement to reflect any change in
circumstances or in Smith & Nephew's
expectations.
◊Trademark of Smith &
Nephew. Certain marks registered US Patent and Trademark
Office.
References:
- Javdan, M., M. Bahadori, and A. Hosseini, Evaluation the
treatment outcomes of Intracapsular femoral neck fractures with
closed or open reduction and internal fixation by screw in
18-50-year old patients in Isfahan from Nov
2010 to Nov 2011. Adv Biomed
Res, 2013. 2: p. 14.
- Sambrook P, Cooper C Osteoporosis. Lancet. 2006 June 17;
367(9527):2010-8
- Pauyo T, Drager J, Albers A, Harvey EJ. Management of
femoral neck fractures in the young patient: A critical
analysis review. World J Orthop 2014; 5(3):
204-217
View original content to download
multimedia:http://www.prnewswire.com/news-releases/smith--nephew-launches-the-conquest-fn-femoral-neck-fracture-system-a-fresh-approach-to-hip-preservation-versus-current-treatment-options-300862498.html
SOURCE Smith & Nephew